KYIV. April 28 (Interfax-Ukraine) – Ukraine should step up efforts in mutual recognition of certificates. This would help to expand exports opportunities of Ukrainian pharmaceutical manufacturers, Board Chairperson of private joint-stock company Indar Liubov Vyshnevska has said.
“The issue is political. Today Ukraine’s GMP certificate and registration certificates are not recognized by any country. It is unclear why we receive these certificates in Ukraine facing many problems. Work of diplomatic missions on signing agreements on mutual recognition [of certificates] is very important for the Ukrainian pharmaceutical sector. If we do not go the way of mutual recognition we would spend at least three years in each country for registration of own products,” she said speaking at the National Forum of Export Support in Kyiv on Wednesday.
She also said that the absence of mandatory European requirements in the sphere of turnover of medicines hinders the implementation of plans of Ukrainian pharmaceutical companies to enter foreign markets.
“Even when we come to Kenya, they put EU legislation on the table and say that meet these requirements and we will register you. This happens not only in Kenya, but in Indonesia, Jordan, Columbia and entire Latin America. Everywhere they ask if we meet EU requirements,” she said.
Vyshnevska said that currency regulation is a large problem for Ukrainian pharmaceutical companies exporting their products.
“The global pharmaceutical market lives under consignation principles. At the moment when our rivals are building consignation warehouses in the regions we are attempting to return currency income. Today we have to include currency exchange risks to the price of goods. Of course, products become less competitive,” she said.
